Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neoplasms
|
1644 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.946 | 465 | 2003 | 2020 | ||||||
melanoma
|
515 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.800 | 0.981 | 464 | 2002 | 2020 | ||||||
Papillary thyroid carcinoma
|
204 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.956 | 367 | 2003 | 2019 | ||||||
Colorectal Carcinoma
|
1962 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.973 | 149 | 2004 | 2020 | ||||||
Thyroid carcinoma
|
145 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.979 | 96 | 2004 | 2019 | ||||||
Malignant Neoplasms
|
1641 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.989 | 95 | 2002 | 2020 | ||||||
Metastatic melanoma
|
42 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 1.000 | 91 | 2004 | 2020 | ||||||
Neoplasm Metastasis
|
327 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.875 | 88 | 2003 | 2019 | ||||||
Thyroid Neoplasm
|
135 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.987 | 79 | 2003 | 2020 | ||||||
Malignant neoplasm of thyroid
|
103 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.986 | 72 | 2004 | 2019 | ||||||
Primary malignant neoplasm
|
1374 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.985 | 68 | 2002 | 2020 | ||||||
Secondary malignant neoplasm of lymph node
|
188 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.789 | 57 | 2004 | 2019 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.980 | 51 | 2005 | 2020 | ||||||
Hairy Cell Leukemia
|
4 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.979 | 48 | 2011 | 2019 | ||||||
Secondary Neoplasm
|
85 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.909 | 44 | 2003 | 2019 | ||||||
Carcinogenesis
|
355 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.929 | 42 | 2003 | 2019 | ||||||
Tumor Cell Invasion
|
169 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.927 | 41 | 2007 | 2018 | ||||||
Thyroid Nodule
|
17 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.947 | 38 | 2006 | 2020 | ||||||
Malignant tumor of colon
|
688 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.943 | 35 | 2004 | 2019 | ||||||
Anaplastic thyroid carcinoma
|
16 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 1.000 | 34 | 2006 | 2019 | ||||||
Histiocytosis, Langerhans-Cell
|
12 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.970 | 33 | 2012 | 2019 | ||||||
Colon Carcinoma
|
275 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.938 | 32 | 2004 | 2019 | ||||||
Non-Small Cell Lung Carcinoma
|
712 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 1.000 | 29 | 2011 | 2019 | ||||||
Ganglioglioma
|
7 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.929 | 28 | 2011 | 2020 | ||||||
Secondary malignant neoplasm of colon and/or rectum
|
68 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 1.000 | 28 | 2009 | 2019 |